Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
about
A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action.Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications.Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.Model of three-dimensional structure of vitamin D receptor and its binding mechanism with 1alpha,25-dihydroxyvitamin D(3).
P2860
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@en
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@nl
type
label
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@en
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@nl
prefLabel
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@en
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@nl
P2093
P2860
P356
P1476
Affinity labeling of the 1 alpha,25-dihydroxyvitamin D3 receptor.
@en
P2093
P2860
P304
P356
10.1074/JBC.271.4.2012
P407
P577
1996-01-01T00:00:00Z